(lp0
S'Cytokinetics, Inc. Reports Fourth Quarter 2016 Financial Results GlobeNewswire  - Feb 16, 2017 16, 2017  -- Cytokinetics, Inc.  reported total revenues for the fourth quarter of 2016 were $33.1 million, compared to $9.8 million, during the same period in 2015.Cantor Fitzgerald Releases a Buy Rating on Cytokinetics Inc - Analyst RatingsPlenty of Catalysts Ahead for Cytokinetics  - Economic Calendar'
p1
aS"Why Cytokinetics, Inc. Got Hammered Today Motley Fool - Sep 1, 2016 What happened. Cytokinetics  is down 13% heading into the closing bell Thursday after announcing plans to start a phase 3 clinical trial for its heart medication omecamtiv mecarbil.Here's Why You Should Buy Cytokinetics, Inc.  As Amgen, Inc. (AMGN ... - TCCCytokinetics , Amgen  to Advance Omecamtiv Mecarbil to Phase 3 - StreetInsider.com"
p2
aS'12.85 MarketWatch - Dec 21, 2009 Cytokinetics Inc. Watchlist CreateCYTKAlert. Open. Last Updated: Mar 17, 2017 12:26 p.m. Real time quote. $ 12.85.'
p3
aS"JMP Securities Bullish on Cytokinetics, Inc.  Following 2Q Update; Sees ... Smarter Analyst - Aug 1, 2016 In light of Cytokinetics, Inc.'s  second-quarter update, JMP Securities analyst Jason Butler remains bullish for the biotech company's pipeline drug-paved road ahead."
p4
aS'Cowen Positive on Cytokinetics, Inc.  as Amgen, Inc.  Opts-in to ... Smarter Analyst - Oct 5, 2016 Cowen top analyst Ritu Baral chimes in on Cytokinetics, Inc.  after Amgen, Inc.  recently opted-in to advance their collaborative drug omecamtiv mercarbil, designed to treat people living with heart failure.'
p5
aS'Cytokinetics to Present at March Investor Conferences Yahoo Finance - Feb 27, 2017 SOUTH SAN FRANCISCO, Calif., Feb. 27, 2017  -- Cytokinetics, Inc.  announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at the following investor conferences:.Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day - GlobeNewswire '
p6
aS"Cytokinetics and Astellas Announce Option Right for Tirasemtiv and Expansion ... GlobeNewswire  - Jul 27, 2016 SOUTH SAN FRANCISCO, Calif. and TOKYO, July 27, 2016  -- Cytokinetics, Inc.   and Astellas Pharma Inc.   today announced that Cytokinetics and Astellas have expanded their&nbsp;...With latest swing, Peninsula biotech tries to double up Lou Gehrig's disease - San Francisco Business Times Cytokinetics Gets $95M in First ALS Deal, Needs Results For More - Xconomy"
p7
aS"The Cytokinetics, Inc.  Rating Reiterated by HC Wainwright Petro Global News 24 - Mar 15, 2017 Cytokinetics, Inc. 's stock had its buy rating reissued by equities researchers at HC Wainwright in a research note issued to investors on Monday.HC Wainwright Reiterates Buy Rating for Cytokinetics, Inc.  - The Cerbat GemCytokinetics, Inc.  Research Coverage Started at Rodman &amp; Renshaw - Sports Perspectives"
p8
aS'Cytokinetics, Inc.  Now Covered by Rodman &amp; Renshaw BNB Daily  - Mar 8, 2017 Cytokinetics logo Stock analysts at Rodman &amp; Renshaw assumed coverage on shares of Cytokinetics, Inc.  in a research report issued to clients and investors on Wednesday, StockTargetPrices.Cytokinetics, Inc.  Given Consensus Recommendation of Buy by Brokerages - The Cerbat GemThe Bayesian Capital Management LP Acquires Shares of 13100 Cytokinetics, Inc ... - DailyQuint'
p9
aS'Cytokinetics Inc  Jumps Higher For Week Business Review - Mar 15, 2017 Pushing higher over the last five sessions are shares of Cytokinetics Inc . The stock has risen 13.04% over that span, yielding profits for savvy traders.'
p10
a.